HOUSTON, Texas – Core Laboratories Inc. (NYSE: CLB), a company currently trading below its InvestingPro Fair Value assessment, announced today the results of its Annual Meeting of Shareholders held on ...

Looking forward, Core Laboratories projects revenue between $128 million and $134 million for Q2 2025, with an expected EPS range of $0.17 to $0.21, suggesting a potential rebound.

Core Laboratories Inc. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance.

News provided by Core Laboratories Inc 07 May, 2025, 17:01 GMT ...

Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") is pleased to announce the opening of its new Unconventional Core Analysis Laboratory in Dammam, Kingdom of Saudi Arabia.

Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") is pleased to announce the opening of its new Unconventional Core Analysis Laboratory in Dammam, Kingdom of Saudi Arabia ...

HOUSTON, May 7, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: CLB) (Core, Core Lab, or the Company) is pleased to announce the openi ...

HOUSTON (AP) — HOUSTON (AP) — Core Laboratories Inc. (CLB) on Wednesday reported a loss of $154,000 in its first quarter. On a per-share basis, the Houston-based company said it had a loss of ...

Core Laboratories has a 1-year low of $12.95 and a 1-year high of $25.13. Core Laboratories (NYSE:CLB – Get Free Report) last posted its earnings results on Wednesday, January 29th.

Core Laboratories Inc. (NYSE: CLB) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Gwen Gresham - Senior Vice ...

Story by Motley Fool Transcribing • 1mo Core Laboratories(NYSE: CLB) Q4 2024 Earnings Call Jan 30, 2025, 8:30 a.m. ET ...